Pressure BioSciences, Inc. to Present at the Southern California Investors Association's Small Cap Conference
WEST BRIDGEWATER, Mass., May 29 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will present at the Southern California Investors Association's Small Cap Investment Conference on Saturday, June 2, 2007 at the Orange County Airport Hilton. Mr. Edward H. Myles, the Company's Senior Vice President of Finance and Chief Financial Officer, will provide a corporate overview at 10:15 am Pacific Time.
About Pressure BioSciences, Inc:
Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio- molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.
About Southern California Investment Association:
SCIA National Small Cap Syndicate is a comprehensive national organization developed to facilitate stock support and capital formation for small and emerging-growth companies. The alliance consists of almost 200 influential member firms plus associates including NASD broker/dealers, bankers, investment advisors, analysts, market makers, venture capitalists, fund managers, media and accredited investors. The syndicate provides equity and debt financing, institutional and retail stock support, market making, and mergers and more. See http://www.sciaonline.org.
Forward Looking Statements
Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2007, in the Company's Annual Report on Form 10-KSB, for the year ended December 31, 2006, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
Visit us at our website http://www.pressurebiosciences.com
SOURCE Pressure BioSciences, Inc.
Released May 29, 2007